Skip to main content
NewslettersWatchlist

Petmed Express Inc(PETS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low4.00
Day High4.14
Open:4.13
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
PR Newswire
PetMeds® Teams Up with Pumpkin® to Help Make Pet Care Simple and Affordable
MarketBeat
One of these 5 Pet Care Stocks Can Be the Next Short Squeeze
MarketBeat
PetMed Express: A Stock To Watch For A Potential Turnaround
Barchart
Why Risk Takers May See Significant Upside in PetMed Express (PETS)
Motley Fool
3 Stocks to Buy Now That Are Yielding 3.5% to 8.8%
MarketBeat
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
MarketBeat
PetMed Express: Charts Say This Could Be The Bottom 
Motley Fool
2 Stocks to Watch on a Quiet Market Day
Motley Fool
2 High-Yield Dividend Stocks Billionaires Can't Stop Buying
Barchart
Why Options Volume for PetMed Express (PETS) Implies a High-Risk Opportunity
Motley Fool
2 Popular Dividend Stocks That Aren't as Safe as They Seem
The Globe and Mail
6 companies benefiting from the pandemic pet boom
Motley Fool
Why Are Pet Stocks Going to the Dogs Again?
ACCESSWIRE
Sidoti's Small-Cap Virtual March Conference
Motley Fool
Why PetMed Express Was a Dog of a Stock This Week
Motley Fool
3 E-Commerce Stocks You Can Buy and Hold for the Next Decade
Motley Fool
This Under-the-Radar E-Commerce Stock Is Aiming to Expand Its Market
Motley Fool
3 Top U.S. Stocks to Watch in January
Motley Fool
2 "Safe" Stocks That Are Anything But
Motley Fool
1 Passive Income Stock to Buy While It's Cheap and 1 to Avoid
MarketBeat
Can Chewy Fetch Double Digit Gains in 2023?
Motley Fool
2 Stocks That Could Surprise Investors in 2023
Globe Newswire
PetMeds® Announces Its First Quarter Financial Results and Declares a Quarterly Dividend of $0.30 Per Share
Globe Newswire
PetMeds® To Announce Its First Quarter Financial Results On July 25, 2022
Business Wire
Shapeways Expands Board of Directors With Appointment of Digital Industry Veteran Raj Batra as Independent Director
MarketBeat
Two Pet Health Stocks To Watch And One To Avoid 
Globe Newswire
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results and Declares a Quarterly Dividend of $0.30 Per Share
Globe Newswire
PetMeds® To Announce Its Fourth Quarter Financial Results On May 9, 2022
Business Wire
Vetster Takes Pet Telehealth Mainstream With $30M USD Series B
Globe Newswire
PetMeds® Announces Exclusive Partnership with Vetster for Pet Telemedicine
Motley Fool
Is PetMed's 4.3% Yield Safe?
Globe Newswire
PetMeds® Announces Its Third Fiscal Quarter Financial Results and Its Quarterly Dividend of $0.30 Per Share

Profile

PetMed Express, Inc. and subsidiaries, d/b/a 1-800-PetMeds (the `Company`), is a leading nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The Company offers consumers an attractive alternative for obtaining pet medications in terms of convenience, price, and speed of delivery. The Company markets its products through national advertising campaigns, which aim to increase the recognition of the `1-800-PetMeds` brand name, and `PetMeds` family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers, and maximize repeat purchases. The majority of the Company's sales are to residents in the United States. The Company's corporate headquarters and distribution facility are located in Delray Beach, Florida.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.